FindTrial
Sign In

Multicenter and Prospective Clinical Study for the Development of Multi-Omics-Based Biomarkers in Acute Myeloid Leukemia

Multicenter and Prospective Clinical Study for the Development of Multi-Omics-Based Biomarkers in Acute Myeloid Leukemia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004825
Enrollment
620
Registered
2020-03-13
Start date
2017-09-21
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Chonnam National University Hospital Hwasun Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with newly diagnosed with acute myeloid leukemia by 4th edition of WHO criteria 19 years of age or greater Patients will receive intensive induction therapy Female patients of childbearing potential must have negative pregnancy test results at entry. Ability to understand the study objectives and willingness to sign written consent

Exclusion criteria

Exclusion criteria: Have other active malignancy Pregnant of lactating women Patients who have no desire to participate in the study Isolated extramedullary myeloid sarcoma Diagnosed with acute promyelocytic leukemia (APL) (FAB classification: M3).

Design outcomes

Primary

MeasureTime frame
Overall survival;Relapse-free survival;treatment related mortality—

Secondary

MeasureTime frame
cumulative incidence of relapse—

Countries

Korea, Republic of

Contacts

Public ContactJae-Sook Ahn

Chonnam National University Hospital Hwasun Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 5, 2026